Description
▪ Introduction
Halotex 5 contains Fluoxymesterone, a pharmaceutical-grade androgenic compound widely used in laboratory research involving androgen receptor stimulation, hepatic metabolism, and synthetic steroid pathways. Produced by Novotex Pharma, this oral preparation is supplied in blister-packed tablets for controlled dosing precision in analytical models. Fluoxymesterone is notable for its high oral bioavailability and strong anabolic-androgenic activity, making it a critical compound in endocrine function and receptor-binding studies.
▪ Product Details
-
Active Ingredient: Fluoxymesterone
-
Dosage Strength: 5 mg per tablet
-
Form: Oral tablets
-
Brand: Novotex Pharma
-
Package Size: 60 tablets (boxed, blister-packed)
-
Intended Use: Laboratory and analytical use
▪ Pharmacokinetics
Fluoxymesterone is a 17α-alkylated oral steroid, structurally modified to resist hepatic breakdown, resulting in high oral activity and a longer half-life in simulated in-vitro systems. It exhibits rapid onset, with a half-life of approximately 9.2 hours. The compound is metabolized hepatically via hydroxylation and oxidation, and excreted primarily through the urine. Its interaction with androgen receptors makes it ideal for use in studies of tissue response, hormonal feedback, and synthetic androgen analogues.
▪ Usage Recommendations
In lab-based studies, common simulation protocols involve daily administration of 5–20 mg depending on the test model and duration. Tablets should remain in original blister packaging to preserve stability, and be handled in sterile environments according to good laboratory practices. Store in a dry, light-protected setting at controlled room temperature.
▪ Disclaimer
This product is intended strictly for laboratory research and analytical use. Not approved for human use or medical treatment. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with health conditions. Must be handled in accordance with local regulatory and laboratory safety standards.